Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of PRO-CTCAE by Patients Receiving Immunotherapy for the Treatment of Malignant Melanoma

NCT03073031 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.

NCT NCT03073031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03073031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of PRO-CTCAE by Patients Receiving Immunotherapy for the Treatment of Malignant Melanoma
Lead sponsor
Odense University Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 10, 2017
Completion date
November 1, 2019
Enrollment
146 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adverse effects